ACTRN12619000361101招募中未知
Exploring the prophylactic benefits of Systane® Complete for individuals with dry eye in an adverse environment
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Normal lid architecture, and closure
- •Dry eye diagnosis according to the TFOS DEWS II diagnostic criteria (Symptoms: DEQ-5 or OSDI and Signs: at least 1 positive finding on NIKBUT/osmolarity/staining).
排除标准
- •Non-normal lid architecture affecting lid closure/blink
- •Artificial tear supplement use < 48 hours prior to study
- •Marked bilateral asymmetry in tear film or ocular surface status
- •Wear of contact lenses within 48 hours of study commencement or during the study
- •Punctal plugs (unless permanent)
- •History of ocular surgery (such as refractive or cataract surgery) in either eye within 3 months of the screening visit
- •History or presence of any ocular disorder or condition in either eye that would likely interfere with the interpretation of the study results or patient safety. This includes but is not limited to significantly reduced visual acuity (below 20/200), significant corneal or conjunctival scarring, pterygium or nodular pinguecula; current ocular infection or inflammation unrelated to dry eye; anterior (epithelial) basement membrane corneal dystrophy or other clinically significant corneal dystrophy or degeneration; ocular herpetic infection.
- •Use of topical medications that might interfere with the study outcomes, or deemed to be contraindicated for participation
- •A systemic condition or disease considered unstable or judged by the investigator to be incompatible with participation in the study (including but not limited to current systemic infection, uncontrolled autoimmune disease, uncontrolled immunodeficiency disease, history of myocardial infarction)
- •Self-reported pregnancy or lactation
- •Active or uncontrolled severe systemic allergy, chronic seasonal allergies, rhinitis or sinusitis requiring treatment (with antihistamines, decongestants, oral or aerosol steroids) at the time of screening
- •Use of medication known to cause ocular drying (including but not limited to antihistamines, tricyclic antidepressants, anxiolytics, antimuscarinics, beta-blocking agents, diuretics, phenothiazines, steroids) within 30 days of the screening visit
- •Participation in any clinical trial with a new active substance or a new device within 30 days of the screening visit
研究者
相似试验
已完成
4 期
A prospective clinical study on the efficacy of collagenase clostridium histolyticum (CCH) injections in the thumb and first web space contractures in Dupuytren*s DiseaseDupuytren's DiseaseFibromatosis palmaris10010761NL-OMON37768niversitair Medisch Centrum Groningen15
进行中（未招募）
不适用
The efficacy of CCH in the thumb and first webspace in Dupuytren's DiseaseDupuytren's DiseaseEUCTR2012-000516-28-NLniversity Medical Centre Groningen
已完成
不适用
exercise-induced muscle damage; prophylactic and therapeutic countermeasuresIRCT20181228042154N1niversity of Sargodha130
招募中
不适用
Camostat Mesilate contained oral wash trialot applicableJPRN-jRCTs031200113ishizaki Yasuriro400
进行中（未招募）
2 期
Evaluation of a couple-based program for promoting a positive transition to parenthoodCouple Relationship Distress and DivorceIndividual Psychological AdjustmentParenting StressMental Health - Studies of normal psychology, cognitive function and behaviourACTRN12607000026426Professor Kim Halford300